Gujarat Kidney Super Speciality Ltd vs Indegene Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Gujarat Kidney & Super Speciality Ltd is ₹ 163.5 as of 30 Oct 15:30 . The P/E Ratio of Gujarat Kidney & Super Speciality Ltd changed from 51.4 on March 2026 to 51.4 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Indegene Ltd changed from 34 on March 2025 to 26 on March 2026 . This represents a CAGR of -12.55% over 2 years The Market Cap of Gujarat Kidney & Super Speciality Ltd changed from ₹ 798.29 crore on March 2026 to ₹ 798.29 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Indegene Ltd changed from ₹ 13878 crore on March 2025 to ₹ 10469 crore on March 2026 . This represents a CAGR of -13.14% over 2 years The revenue of Gujarat Kidney & Super Speciality Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 34.98 crore. This represent the decline of -100% The revenue of Indegene Ltd for the Sep '26 is ₹ 1137 crore as compare to the Jun '26 revenue of ₹ 1092 crore. This represent the growth of 4.14% The ebitda of Gujarat Kidney & Super Speciality Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 9.07 crore. This represent the decline of -100% The ebitda of Indegene Ltd for the Sep '26 is ₹ 200.7 crore as compare to the Jun '26 ebitda of ₹ 203.2 crore. This represent the decline of -1.23% The net profit of Gujarat Kidney & Super Speciality Ltd changed from ₹ 2.96 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The net profit of Indegene Ltd changed from ₹ 87.7 crore to ₹ 112.3 crore over 10 quarters. This represents a CAGR of 10.40% The Dividend Payout of Gujarat Kidney & Super Speciality Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Indegene Ltd changed from 26.42 % on March 2025 to 25.54 % on March 2026 . This represents a CAGR of -1.68% over 2 years .

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre.
Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad. The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care.

About Indegene Ltd

Indegene Limited was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad.
Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016.
Thereafter, Company converted to a Public Company with change in name to Indegene Limited' on November 17, 2022. The Company is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency.
As a specialized company, it combine healthcare domain expertise, fit-for-purpose technology, and an agile operating model to solve the most complex problems in the healthcare industry.

FAQs for the comparison of Gujarat Kidney & Super Speciality Ltd and Indegene Ltd

Which company has a larger market capitalization, Gujarat Kidney & Super Speciality Ltd or Indegene Ltd?

Market cap of Gujarat Kidney & Super Speciality Ltd is 1,289 Cr while Market cap of Indegene Ltd is 14,161 Cr

What are the key factors driving the stock performance of Gujarat Kidney & Super Speciality Ltd and Indegene Ltd?

The stock performance of Gujarat Kidney & Super Speciality Ltd and Indegene Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Kidney & Super Speciality Ltd and Indegene Ltd?

As of November 1, 2026, the Gujarat Kidney & Super Speciality Ltd stock price is INR ₹163.5. On the other hand, Indegene Ltd stock price is INR ₹587.65.

How do dividend payouts of Gujarat Kidney & Super Speciality Ltd and Indegene Ltd compare?

To compare the dividend payouts of Gujarat Kidney & Super Speciality Ltd and Indegene Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.